- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2020-10-19
2026-10-19
2030-10-19
1000
NCT05179824
Tempus AI
Tempus AI
OBSERVATIONAL
Tempus Priority Study: A Pan-tumor Observational Study
Observational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific eligibility criteria outlined for each cohort with the goal of conducting research to advance cancer care and create a dataset that furthers cancer research.
The Study will collect combined clinical and molecular health information for cancer patients in the United States from multiple academic medical centers and community oncology practices. Participants who agree to join the Study will have their molecular profiling results, associated clinical health information, and longitudinal outcomes health information collected by the participating Institution for submission to Tempus. The specific goal of the Study is to create an outcomes-based dataset for future research to improve cancer treatment.
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2021-12-16 | N/A | 2025-05-05 |
2021-12-16 | N/A | 2025-05-06 |
2022-01-05 | N/A | 2025-05 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| : Group 1: Standard of Care (SOC) CGP This group will facilitate collection of paired clinical and molecular data done as part of the standard of care or routine clinical care across a variety of institutions. The goal of Group 1 is to capture a broad range of participants to better understan | OTHER: Observation
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Create robust data set of health information | To create a robust data set of health information about cancer patients who receive comprehensive genomic profiling in order to facilitate future novel precision medicine research | Up to 10 years |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Document clinical events for patients who have had comprehensive genomic profiling | To document specific clinical events in relation to diagnosis, treatment, and outcomes for patients who have had comprehensive genomic profiling | Up to 10 years |
| Evaluate longitudinal paired tissue and cell free molecular testing | To evaluate the feasibility of longitudinal paired tissue and cell free molecular testing of participants with specific types of cancer, mutations, or therapies | Up to 10 years |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
